Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the UrotheliumJoaquim Bellmunt, E. Batiste-Alentorn, A. Sáenz et al.|Journal of Clinical Oncology|2000Cited by 191
Predicting response and survival in chemotherapy-treated triple-negative breast cancerAleix Prat, Emilio Alba, Aňa Lluch et al.|British Journal of Cancer|2014Cited by 113
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cellsJordi Codony‐Servat, Joan Albanell|Molecular Cancer Therapeutics|2006Cited by 107